A Meta-Analysis of the Relationship between Cigarette Smoking and Incidence of Myelodysplastic Syndromes

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Tong, Hongyan ^a,b   Hu, Chao ^a,b   Yin, Xiufeng ^a,b   Yu, Mengxia ^c   Yang, Jun ^a   Jin, Jie ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c NINGBO UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISEASE ASSOCIATION; EUROPE; GENETIC HETEROGENEITY; HUMAN; INCIDENCE; MYELODYSPLASTIC SYNDROME; NEWCASTLE OTTAWA SCALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; RATING SCALE; REFRACTORY ANEMIA; REFRACTORY ANEMIA WITH RINGED SIDEROBLASTS; RISK FACTOR; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SMOKING; SYSTEMATIC REVIEW; UNITED STATES; FACTUAL DATABASE; FEMALE; MALE; META ANALYSIS; MYELODYSPLASTIC SYNDROMES; ODDS RATIO; RISK;

DATABASES, FACTUAL; FEMALE; HUMANS; INCIDENCE; MALE; MYELODYSPLASTIC SYNDROMES; ODDS RATIO; RISK; SEX FACTORS; SMOKING;

EID: 84879274650     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067537     Document Type: Article

References (34)

1. Greenberg PL, Young NS, Gattermann N (2002) Myelodysplastic syndromes. Hematology Am Soc Hematol Educ Program: 136-161.
2. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, et al. (1982) Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51: 189-199.
3. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, et al. (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89: 2079-2088.
4. Group IW (2004) Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum 83: 1-1438.
5. Zhang J, Yu KF, (1998) What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 280: 1690-1691.
6. Wells G, Shea B, O'Connell D (2009) Ottawa Hospital Research Institute: The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
7. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
8. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
9. Ma X, Lim U, Park Y, Mayne ST, Wang R, et al. (2009) Obesity, Lifestyle Factors, and Risk of Myelodysplastic Syndromes in a Large US Cohort. American Journal of Epidemiology 169: 1492-1499.
10. Lv L, Lin G, Gao X, Wu C, Dai J, et al. (2011) Case-control study of risk factors of myelodysplastic syndromes according to World Health Organization classification in a Chinese population. American Journal of Hematology 86: 163-169.
11. Björk J, Johansson B, Broberg K, Albin M, (2009) Smoking as a risk factor for myelodysplastic syndromes and acute myeloid leukemia and its relation to cytogenetic findings: A case-control study. Leukemia Research 33: 788-791.
12. Pekmezovic T, Suvajdzic Vukovic N, Kisic D, Grgurevic A, Bogdanovic A, et al. (2006) A case-control study of myelodysplastic syndromes in Belgrade (Serbia Montenegro). Annals of Hematology 85: 514-519.
13. Strom SS, Gu Y, Gruschkus SK, Pierce SA, Estey EH, (2005) Risk factors of myelodysplastic syndromes: a case-control study. Leukemia 19: 1912-1918.
14. Dalamaga M, Petridou E, Cook FE, Trichopoulos D, (2002) Risk factors for myelodysplastic syndromes: a case-control study in Greece. Cancer Causes Control 13: 603-608.
15. Nisse C, Haguenoer JM, Grandbastien B, Preudhomme C, Fontaine B, et al. (2001) Occupational and environmental risk factors of the myelodysplastic syndromes in the North of France. Br J Haematol 112: 927-935.
16. Bjork J, Albin M, Mauritzson N, Stromberg U, Johansson B, et al. (2000) Smoking and myelodysplastic syndromes. Epidemiology 11: 285-291.
17. Nagata C, Shimizu H, Hirashima K, Kakishita E, Fujimura K, et al. (1999) Hair dye use and occupational exposure to organic solvents as risk factors for myelodysplastic syndrome. Leuk Res 23: 57-62.
18. Pasqualetti P, Festuccia V, Acitelli P, Collacciani A, Giusti A, et al. (1997) Tobacco smoking and risk of haematological malignancies in adults: a case-control study. Br J Haematol 97: 659-662.
19. Ido M, Nagata C, Kawakami N, Shimizu H, Yoshida Y, et al. (1996) A case-control study of myelodysplastic syndromes among Japanese men and women. Leuk Res 20: 727-731.
20. West RR, Stafford DA, Farrow A, Jacobs A, (1995) Occupational and environmental exposures and myelodysplasia: a case-control study. Leuk Res 19: 127-139.
21. Mele A, Szklo M, Visani G, Stazi MA, Castelli G, et al. (1994) Hair dye use and other risk factors for leukemia and pre-leukemia: a case-control study. Italian Leukemia Study Group. Am J Epidemiol 139: 609-619.
22. Crane MM, Keating MJ, (1991) Exposure histories in acute nonlymphocytic leukemia patients with a prior preleukemic condition. Cancer 67: 2211-2214.
23. Pisani P, Parkin DM, Bray F, Ferlay J, (1999) Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83: 18-29.
24. Brugnone F, Perbellini L, Maranelli G, Romeo L, Alexopoulos C, et al. (1990) [Effects of cigarette smoking on blood and alveolar air levels of benzene]. Med Lav 81: 101-106.
25. Vigliani EC, Saita G, (1964) Benzene and Leukemia. N Engl J Med 271: 872-876.
26. Aksoy M, Dincol K, Erdem S, Dincol G, (1972) Acute leukemia due to chronic exposure to benzene. Am J Med 52: 160-166.
27. Steensma DP, (2006) Are myelodysplastic syndromes "cancer"? Unexpected adverse consequences of linguistic ambiguity. Leuk Res 30: 1227-1233.
28. Sopori ML, Kozak W, (1998) Immunomodulatory effects of cigarette smoke. J Neuroimmunol 83: 148-156.
29. Calderon-Ezquerro C, Sanchez-Reyes A, Sansores RH, Villalobos-Pietrini R, Amador-Munoz O, et al. (2007) Cell proliferation kinetics and genotoxicity in lymphocytes of smokers living in Mexico City. Hum Exp Toxicol 26: 715-722.
30. Mehta H, Nazzal K, Sadikot RT, (2008) Cigarette smoking and innate immunity. Inflamm Res 57: 497-503.
31. Moszczynski P, Zabinski Z, Moszczynski P Jr, Rutowski J, Slowinski S, et al. (2001) Immunological findings in cigarette smokers. Toxicol Lett 118: 121-127.
32. McMillan SA, Douglas JP, Archbold GP, McCrum EE, Evans AE, (1997) Effect of low to moderate levels of smoking and alcohol consumption on serum immunoglobulin concentrations. J Clin Pathol 50: 819-822.
33. Strom SS, Velez-Bravo V, Estey EH, (2008) Epidemiology of myelodysplastic syndromes. Semin Hematol 45: 8-13.
34. Mauritzson N, Johansson B, Rylander L, Albin M, Stromberg U, et al. (2001) The prognostic impact of karyotypic subgroups in myelodysplastic syndromes is strongly modified by sex. Br J Haematol 113: 347-356.